Novartis Takes Top Spot, Previously Held by GlaxoSmithKline Since June
PHILADELPHIA and LONDON, Oct. 16 /CNW/ -- Thomson Scientific, part of The
Thomson Corporation (NYSE: TOC; TSX: TOC) and leading provider of information
solutions to the worldwide research and business communities, today announced
the availability of its most recent quarterly review of scientific literature
on drugs and therapies. "Who is Making the Biggest Splash?" was created to
provide an objective assessment of how this tremendous volume of research is
being received within the clinical community and to give expert measured
insight into organizations that helped to shape professional opinions. In this
quarterly review, Thomson Scientific has assessed the quantity and quality of
the materials published by pharmaceutical companies, research institutions and
other non-commercial from April - June 2007 to identify which organization has
made the biggest splash.
Novartis gained pole position in this quarter's analysis, knocking
GlaxoSmithKline out of the top spot for the first time since June 2006.
Researchers affiliated with the firm issued 82 articles, abstracts or
scientific posters between April and June 2007, more than the 73 identified in
the previous quarter. The company maintained its solid Thomson Source Score of
76. Three of the other organizations at the top of the list (AstraZeneca,
GlaxoSmithKline, and Eli Lilly) this quarter also ranked in the top five last
"The international pharmaceutical industry is among the most active
sponsors of scientific research, so it is understandable that our findings
confirm that scientific articles affiliated with, or sponsored by,
pharmaceutical companies provide a robust level of information for readers of
scientific journals," said Larry Liberti, VP, General Manager, Thomson
Pharmaceutical Services. "Our one-of-a-kind report finds that many
pharmaceutical companies have good grounds for saying what they say - and
judging by their source score, say it well."
Other key findings include:
-- GlaxoSmithKline drops to fourth, with 18 less sources than Novartis.
-- Big Pharma features prominently, representing all entries except for
the two US National Institutes of Health.
-- There was a notable change from previous quarters where at least one
discovery or biotechnology company was represented in the top ten.
-- No companies in the top 15 exceed a Thomson Source Score of 80%.
-- The top six entries are among the world's leading pharmaceutical
Findings are based on information compiled from Thomson Pharma(R) and the
Thomson Message Mapping System(SM), which provides data to the pharmaceutical
industry in real-time, evaluating specific drugs and therapies against
competitors as new studies are being published, helping pharmaceutical
companies to measure the overall impact of published scientific information.
For a full copy of the report with analysis, please visit:
About The Thomson Corporation
The Thomson Corporation (www.thomson.com) is a global leader in providing
essential electronic workflow solutions to business and professional
customers. With operational headquarters in Stamford, Conn., Thomson provides
value-added information, software tools and applications to professionals in
the fields of law, tax, accounting, financial services, scientific research
and healthcare. The Corporation's common shares are listed on the New York and
Toronto stock exchanges (NYSE: TOC; TSX: TOC).
Thomson Scientific is a business of The Thomson Corporation. Its
information solutions assist professionals at every stage of research and
development-from discovery to analysis to product development and
distribution. Thomson Scientific information solutions can be found at
For further information:
For further information: Eoin Bedford of Thomson Scientific, +44 207 433
4691, email@example.com Web Site: http://www.scientific.thomson.com